fda bpc 157 category 2 bulk drug substance compounding list Peptide Reclassification 2026: What It Means for Providers THE PCCA BLOG | FDA
THE PCCA BLOG FDA Guidance Explained: Compounding with Bulk Dru BPC 157 FDA Approval Status 2026: Clinical Trials Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. Industry Update: Interim 503A and 503B Bulks Lists New Revisions
Pay in 4 interest-free payments of $6.84 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3


